
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Iron bisglycinate (Ferrochel) is a chelated iron supplement where iron is bound to two glycine amino acids for enhanced absorption. It bypasses typical iron absorption limitations in the duodenum through peptide transport pathways, reducing gastrointestinal side effects.

Reported Benefits (Provisional)
Origin & History

Iron Bisglycinate is a chelated form of iron, where iron is bound to glycine, an amino acid. This form is designed to enhance absorption and reduce gastrointestinal side effects.
Research Narrative (Provisional)
Studies suggest that Iron Bisglycinate is more bioavailable and causes fewer gastrointestinal issues compared to other forms of iron. Randomized controlled trials have shown its effectiveness in improving iron status.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"minerals": {"iron": {"compound": "Iron Bisglycinate", "concentration": "20 mg per serving", "bioavailability": "High, due to chelation with glycine"}}, "bioactive_compounds": {"glycine": {"concentration": "Varies depending on formulation, typically 100 mg per serving", "role": "Enhances iron absorption and reduces gastrointestinal side effects"}}, "vitamins": {"vitamin_C": {"concentration": "Optional addition in some formulations, typically 60 mg per serving", "role": "Enhances iron absorption"}}}
Reported Mechanism (Provisional)
Iron bisglycinate utilizes the peptide transport system (PepT1) in the small intestine rather than competing with other minerals at the divalent metal transporter 1 (DMT1). The glycine chelation protects iron from precipitation with phytates and tannins, maintaining stability at higher pH levels. Once absorbed, iron is incorporated into hemoglobin via heme synthesis and ferritin for storage.
Clinical Narrative (Provisional)
Multiple randomized controlled trials demonstrate iron bisglycinate's superior bioavailability compared to ferrous sulfate, with 2.3-fold higher absorption rates. A 12-week study of 124 iron-deficient women showed 90% achieved normal ferritin levels with 25mg daily iron bisglycinate versus 65% with ferrous sulfate. Clinical evidence shows 75% fewer gastrointestinal side effects including nausea and constipation. Most studies range from 8-16 weeks with sample sizes of 50-200 participants, providing moderate-quality evidence.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







